This half day course is designed for those who want to understand the fundamentals of pharmaceutical commercialisation and how early-stage companies should approach it. 

The course aims to cover the following:
•    What exactly is commercialisation
•    When should companies start thinking about it
•    Demystifying sales, marketing and market access
•    Why a commercial plan matters for investors/partners
•    How R&D and commercial teams can work better together
•    Why a commercial mindset is critical for everyone to have
•    Key commercial questions executives should be able to answer 
•    What commercial knowledge you need to successfully negotiate

By the end of the course, attendees will have a better understanding of the key principles of commercialisation, be able to hold productive conversations with potential investors and create assets that deliver maximum value.

Costs:
One Nucleus Gold: £52.50 + VAT
One Nucleus Silver: £63.75 + VAT
Non-members: £75 + VAT